Literature DB >> 1908833

Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains.

J S Fomsgaard1, A Fomsgaard, N Høiby, B Bruun, C Galanos.   

Abstract

Lipopolysaccharides (LPS) were extracted and purified from the type strain and from a clinical isolate of Branhamella catarrhalis. Chemical analysis revealed the presence of glucose, galactose, and glucosamine in different molar proportions in the LPS from these two isolates, whereas there was no difference between the two isolates in the ratios of ketodeoxyoctonate, phosphate, and the fatty acids C12, 3-OH-C12, and 3-OH-C11 present. Heptose or 3-OH-C14 was not detectable in either preparation. LPS from both strains appeared semirough according to sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis, presenting a core polysaccharide plus one repeating unit. Immunoblotting, passive hemolysis, and hemolysis inhibition assays using anti-LPS antibodies from immunized rabbits demonstrated cross-reactivity between the LPS preparations; however, antigenic dissimilarities were also found, suggesting that more than one serotype may exist. The lipid A isolated from the two LPS was serologically identical and exhibited cross-reactivity with lipid A of members of the family Enterobacteriaceae. The B. catarrhalis LPS were biologically active, causing lethality in D-galactosamine-sensitized C57/BL6 mice and inducing Limulus amoebocyte lysate gelation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908833      PMCID: PMC258182          DOI: 10.1128/iai.59.9.3346-3349.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  A colorimetric method for the determination of N-acetylglucosamine and N-acetylchrondrosamine.

Authors:  W T Morgan; L A Elson
Journal:  Biochem J       Date:  1934       Impact factor: 3.857

2.  In honor of Dr. Sarah Branham, a star is born. The realization of Branhamella catarrhalis as a respiratory pathogen.

Authors:  R J Wallace; D M Musher
Journal:  Chest       Date:  1986-09       Impact factor: 9.410

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Branhamella catarrhalis--an emerging human pathogen.

Authors:  G V Doern
Journal:  Diagn Microbiol Infect Dis       Date:  1986-03       Impact factor: 2.803

5.  A 2-year survey of Branhamella catarrhalis in a general hospital.

Authors:  J M Smith; B M Lockwood
Journal:  J Hosp Infect       Date:  1986-05       Impact factor: 3.926

6.  Studies on the cellular and free lipopolysaccharides from Branhamella catarrhalis.

Authors:  K G Johnson; I J McDonald; M B Perry
Journal:  Can J Microbiol       Date:  1976-04       Impact factor: 2.419

7.  Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels.

Authors:  A Fomsgaard; M A Freudenberg; C Galanos
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

8.  Comparative immunochemistry of lipopolysaccharides from typable and polyagglutinable Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis.

Authors:  A Fomsgaard; R S Conrad; C Galanos; G H Shand; N Høiby
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

9.  Branhamella catarrhalis: fatty acid and lipopolysaccharide analysis of an atypical strain from blood culture.

Authors:  J Wüst; G V Doern; A von Graevenitz
Journal:  Diagn Microbiol Infect Dis       Date:  1988-06       Impact factor: 2.803

10.  Acute otitis media caused by Branhamella catarrhalis: biology and therapy.

Authors:  G F Van Hare; P A Shurin; C D Marchant; N A Cartelli; C E Johnson; D Fulton; S Carlin; C H Kim
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb
View more
  19 in total

1.  Bactericidal monoclonal antibody against Moraxella catarrhalis lipooligosaccharide cross-reacts with Haemophilus Spp.

Authors:  Raina T Gergova; Ianko D Iankov; Iana H Haralambieva; Ivan G Mitov
Journal:  Curr Microbiol       Date:  2007-01-05       Impact factor: 2.188

2.  Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.

Authors:  X X Gu; J Chen; S J Barenkamp; J B Robbins; C M Tsai; D J Lim; J Battey
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly.

Authors:  Katie J Edwards; Simon Allen; Bradford W Gibson; Anthony A Campagnari
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

Review 4.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 5.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.

Authors:  Shengqing Yu; Xin-Xing Gu
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

7.  Roles of 3-deoxy-D-manno-2-octulosonic acid transferase from Moraxella catarrhalis in lipooligosaccharide biosynthesis and virulence.

Authors:  Daxin Peng; Biswa P Choudhury; Ronald S Petralia; Russell W Carlson; Xin-Xing Gu
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

8.  A monoclonal antibody reactive with a common epitope of Moraxella (Branhamella) catarrhalis lipopolysaccharides.

Authors:  K Oishi; H Tanaka; F Sonoda; S Borann; K Ahmed; Y Utsunomiya; K Watanabe; T Nagatake; M Vaneechoutte; G Verschraegen; K Matsumoto
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

9.  Lack of serotype-specific antibody response to lipopolysaccharide antigens of Moraxella catarrhalis during lower respiratory tract infection.

Authors:  M Rahman; T Holme; I Jönsson; A Krook
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

10.  Endotoxin activity of Moraxella osloensis against the grey garden slug, Deroceras reticulatum.

Authors:  Li Tan; Parwinder S Grewal
Journal:  Appl Environ Microbiol       Date:  2002-08       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.